L. reuteri DSM 17938 + L. reuteri ATCC PTA 6475 for Upper GI Health - a podcast by Bio-Practica Nutraceuticals

from 2020-06-22T16:46

:: ::

Dr Veronica Ojetti is a gastroenterologist with a special interest in therapeutic strategies for Helicobacter pylori infections. Dr Ojetti is currently Adjunct Professor of Gastroenterology and Emergency Medicine at the A. Gemelli Catholic University in Rome, Italy.
She is a member of the Italian Society of Gastroenterology (SIGE), European Helicobacter and Microbiota Study Group (EHMSG), and of the Italian Society of Emergency Medicine (SIMEU).
Professor Ojetti is also on the editorial board of the European Review for Medical and Pharmacological Sciences. She has authored more than 130 papers and is an active researcher, clinician, and speaker.

CLINICAL PEARLS & RESEARCH HIGHLIGHTS FROM THIS PODCAST INCLUDE…
· Explore short- and long term-consequences of gastritis, leaky gut, and Helicobacter pylori infections
· Discuss the latest human clinical trial data on Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 6475
· Examine the anti-pathogenic, anti-inflammatory and gut healing benefits of this combination of specific Lactobacillus reuteri strains

Further episodes of Bio-Practica Professional Podcast Series

Further podcasts by Bio-Practica Nutraceuticals

Website of Bio-Practica Nutraceuticals